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Hospital, Chittagong, BangladeshAbstractTwo hundred and thirty-eight faecal samples from crows foraging
on hospital wastes were analysed for extended-spectrum
β-lactamase (ESBL)-producing Enterobacteriaceae. ESBL-producing
crow isolates were characterized and compared with 31 patient
isolates. Among the crows, 59% carried ESBL producers. These
included Escherichia coli, Klebsiella pneumoniae, Raoultella terrigena
and Enterobacter cloacae harbouring the genes for CTX-M-1,
CTX-M-15, CTX-M-55, CTX-M-79, and CTX-M-14. Human
isolates carried only the CTX-M-15 gene. Two-thirds of crow
E. coli isolates and all human E. coli isolates were multidrug
resistant. Crows and patients shared E. coli sequence types,
including the epidemic E. coli O25b-ST131 clone. The scavenging
behaviour of crows at poorly managed hospital waste dumps
made them potential reservoirs of antibiotic resistance, including
ESBLs.
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constitute a serious emerging public health concern globally [1].
ESBL CTX-M types have been the most successful in recent
years [2]. Plasmids with CTX-M-encoding genes are usually
harboured by members of the Enterobacteriaceae family, mostly
Escherichia coli. E. coli can be both commensal and an indicator of
antibiotic resistance contamination of the environment [3,4]. A
lack of hospital waste management could be one of several
sources for environmental dissemination of multiresistant bac-
teria [5,6]. Medical facilities in Bangladesh rarely have internal
waste treatment facilities with incinerators in the hospitals. The
open hospital waste dumps are inviting for birds such as crows
(Hindu Online, 2003, http://www.thehindu.com/thehindu/2003/
03/24/stories/2003032406540300.htm) [7]. The house crow
(Corvus splendens) is widely distributed in South Asia, and lives in
close contact with humans [8]. Faecal samples from crows
foraging on hospital grounds in Bangladesh were used to explore
the level of environmental contamination by antibiotic-resistant
bacteria resulting from poor management of hospital waste.
Special attention was paid to E. coli with CTX-M-production. In
addition, isolates from crows were compared with those from
patients to investigate whether crows were involved in the
environmental dissemination of clinically important pathogens
such as the E. coli O25b-ST131 clone.
Crow faecal samples were collected during February 2010
from the grounds of Rajshahi Medical College Hospital (n = 200)
and Chittagong Medical College Hospital (n = 38) in Bangladesh.
ESBL-producing Enterobacteriaceae were screened and isolated
according to a previously described method [9], and their
presence was conﬁrmed with the cefpodoxime/
cefpodoxime + clavulanic acid double-disk method (MAST Di-
agnostics, Bootle, UK). Clinical ESBL-producing E. coli (n = 15)
and Klebsiella pneumoniae (n = 16) isolates were collected during
2011 from the aforementioned hospitals. All isolates were
screened for blaCTX-M genotypes with a PCR protocol [10],
revealing the group designation (CTX-M-I/II/III/IV) of blaCTX-M-
positive isolates. Positive PCR products were further sequenced.
E. coli isolates from crows and patients were tested for antibiotic
susceptibility according to EUCAST criteria. Two antibiotic
panels were used. The crow panel included ampicillin, cefadroxil,
cefuroxime, mecillinam, trimethoprim–sulphamethoxazole,
streptomycin, gentamicin, tetracycline, tigecycline,Diseases. Published by Elsevier Ltd. All rights reserved
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cin. The human panel included imipenem and meropenem, but
not tetracycline, streptomycin, and cefadroxil. Clonal related-
ness among randomly chosen ESBL-producing E. coli (n = 43) and
K. pneumoniae (n = 33) isolates from crows (E. coli, n = 28;
K. pneumoniae, n = 17) and patients (E. coli, n = 15; K. pneumoniae,
n = 16) were determined by repetitive sequenced-based PCR [9].
All CTX-M-producing E. coli isolates were additionally screened
for the pabB gene with an O25b-ST131 clone allele-speciﬁc PCR
[11]. E. coli isolates from crows (n = 27) and patients (n = 14)
were characterized by multilocus sequence typing (MLST)
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). To control theO25b-
ST131 clone allele-speciﬁc PCR, 11 isolates that were positive
for pabB were also sequence typed.
One hundred and forty-one of 238 (59.2%) crows harboured
ESBL-producing Enterobactericeae. The species distribution was
as follows: E. coli, n = 154; K. pneumoniae, n = 21; Raoultella
terrigena, n = 14; Enterobacter cloacae, n = 4; Citrobacter freundii,
n = 3; Proteus mirabilis, n = 1; and Escherichia species, n = 1.
CTX-M genotypes were found in 189 (95.4%) of the ESBL-
producing isolates. Different CTX-M genotypes were distrib-
uted among different species (Table 1). The most common was
CTX-M-15 (95.2%; 180/189). CTX-M-positive E. coli isolates
(n = 150) from crows were found to be resistant to different
antibiotics: tetracycline (72%), trimethoprim–
sulphamethoxazole (57.3%), nalidixic acid (56.6%), ciproﬂoxa-
cin (41.3%), streptomycin (34%), chloramphenicol (11.3%),
gentamicin (10.3%), mecillinam (2%), and nitrofurantoin (3.3%).
No resistance to tigecycline was found; however, 100 (66.7%)
of them were multidrug resistant (three to seven antibiotic
classes). All 31 human isolates carried CTX-M-15. Apart from
the 100% resistance to ampicillin and cephalosporins (cefadroxil
and cefuroxime), the resistance rates were as follows: cipro-
ﬂoxacin, 93.3%; trimethoprim–sulphamethoxazole, 60%;
gentamicin, 33.3%; chloramphenicol, 26.6%; nitrofurantoin,
13.3%; mecillinam, 6.6%; and tigecycline, 6.6%. No resistance to
imipenem or meropenem was found, but all had multidrug
resistance (three to eight antibiotic classes). E. coli andTABLE 1. CTX-M types in members of the Enterobacteriaceae
family derived from crows
Bacterial species No. of isolates ESBL type
Escherichia coli 150 CTX-M-1, CTX-M-14-like,
CTX-M-15, CTX-M-55,
CTX-M-79
Escherichia species 1 CTX-M-15
Klebsiella pneumoniae 17 CTX-M-15
Raoultella terrigena 14 CTX-M-15
Enterobacter cloacae 3 CTX-M-15
Citrobacter freundii 3 CTX-M-15
Proteus mirabilis 1 CTX-M-14-like
ESBL, extended-spectrum β-lactamase.
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repetitive sequenced-based PCR. However, there were a few
common E. coli clusters found in both humans and crows. None
of the genotypes of human K. pneumoniae isolates were iden-
tiﬁed among the crows, but crows from the two hospital areas
shared K. pneumoniae genotypes. The epidemic E. coli O25b-
ST131 clone was found in patients (n = 5) from the Rajshahi
Medical College Hospital and in crows (n = 6) from both
hospitals. The E. coli sequence types determined with MLST are
shown in Table 2. ST131 and ST38 (ST38 clonal complex) were
shared between humans and crows. All isolates identiﬁed as
belonging to the O25b-ST131 clone with the PCR method
were also identiﬁed as ST131 with MLST. The ST354 (ST354
clonal complex) was common in crows from both locations.
This study suggests that crows are potential carriers of
clinical CTX-M types. Independently of bacterial species, the
CTX-M-15 type predominated both in crows and in humans.
Globally, this is the most abundant type [1]. Crows harboured
CTX-M-79, a type associated with humans in China [12].
Crows also carried CTX-M-14-like, which has been reported in
clinical isolates in Taiwan [13]. The crows not only reﬂected the
antibiotic resistance of the human ESBL-producing isolates,
albeit at a lower level, but also shared strains with the patients.
One of these strains was the clinically important E. coli clone
O25b-ST131. This clone is widely distributed globally, and has
been estimated to represent approximately 20% of the
expansion of ESBL-producing E. coli [14]. It was therefore not
surprising to ﬁnd it among both patients and crows, but it is
worrying that it could spread that easily within the crows.
Apart from ST131, the crows were carrying three human-
associated sequence types, i.e. the ST38 (ST38 clonal com-
plex), ST46 (ST46 clonal complex), and ST58 (ST155 clonal
complex). ST58 (ST155 clonal complex) has been reported in
humans [15]. The results showed that the crows had a higher
rate of carriage of ESBL producers than all other birds species
studied in the world, which so far include gulls in different
countries [16–18], and wild ducks, poultry and gulls in
Bangladesh [4,9]. Hospital waste is known to be loaded with
multidrug-resistant bacteria, including ESBL-producing Enter-
obacteriaceae [19]. Scavenging of this hospital waste by crows
made them both reservoirs and active spreaders of ESBL pro-
ducers, including the E. coli O25b-ST131 clone, into the envi-
ronment. Improper management of hospital waste and hygiene,
lack of treatment of hospital sewage and movement of scav-
engers into the hospital dumps are probably the main
contributory factors to the high carriage rate of ESBL-
producing bacteria in the studied crow populations. Nation-
wide programmes are necessary to improve the management of
both hospital waste and sewage, in order to control further
environmental spread.ctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1000.e1–1000.e4
TABLE 2. Genotypic characterization of Escherichia coli from
human patients and crows
Source Location CTX-M type Sequence type
1 Human RMCH/MDC CTX-M-15 ST694
2 Human RMCH/MDC CTX-M-15 ST3493
3 Human RMCH/MDC CTX-M-15 ST2659
4 Human RMCH/MDC CTX-M-15 ST410 (ST23 clonal complex)
5 Human RMCH/MDC CTX-M-15 ST617 (ST10 clonal complex)
6 Human RMCH/MDC CTX-M-15 O25b-ST131
7 Human RMCH/MDC CTX-M-15 O25b-ST131
8 Human RMCH/MDC CTX-M-15 O25b-ST131
9 Human RMCH/MDC CTX-M-15 O25b-ST131
10 Human RMCH/MDC CTX-M-15 O25b-ST131
11 Human RMCH/MDC CTX-M-15 ST648
12 Human RMCH/MDC CTX-M-15 ST167
13 Human RMCH/MDC CTX-M-15 —
14 Crow RMCH/MDC CTX-M-15 ST46 (ST46 clonal complex)
15 Crow RMCH/MDC CTX-M-15 ST38 (ST38 clonal complex)
16 Crow RMCH/MDC CTX-M-15 O25b-ST131
17 Crow RMCH/MDC CTX-M-15 ST3482a
18 Crow RMCH/MDC CTX-M-15 ST58 (ST155 clonal complex)
19 Crow RMCH/MDC CTX-M-15 —
20 Crow RMCH/MDC CTX-M-15 ST1664
21 Crow RMCH/MDC CTX-M-14-like ST405 (ST405 clonal complex)
22 Crow RMCH/MDC CTX-M-15 ST3482a
23 Crow RMCH/MDC CTX-M-15 ST58 (ST155 clonal complex)
24 Crow RMCH/MDC CTX-M-15 ST3486a
25 Crow RMCH/MDC CTX-M-15 ST3780a
26 Crow RMCH/MDC CTX-M-1 ST3781a
27 Crow RMCH/MDC CTX-M-14-like O25b-ST131
28 Crow RMCH/MDC CTX-M-15 —
29 Crow RMCH/MDC CTX-M-14-like O25b-ST131
30 Crow RMCH/MDC CTX-M-15 ST354 (ST354 clonal complex)
31 Crow RMCH/MDC CTX-M-15 ST3487a
32 Crow RMCH/MDC CTX-M-15 ST2141
33 Crow RMCH/MDC CTX-M-15 ST3488a
34 Crow RMCH/MDC CTX-M-15 ST354 (ST354 clonal complex)
35 Human Chittagong Medical
College Hospital
CTX-M-15 ST38 (ST38 clonal complex)
36 Human Chittagong Medical
College Hospital
CTX-M-15 ST101 (ST101 clonal complex)
37 Crow Chittagong Medical
College Hospital
CTX-M-15 O25b-ST131
38 Crow Chittagong Medical
College Hospital
CTX-M-15 ST3135
39 Crow Chittagong Medical
College Hospital
CTX-M-15 ST1706
40 Crow Chittagong Medical
College Hospital
CTX-M-15 ST354 (ST354 clonal complex)
41 Crow Chittagong Medical
College Hospital
CTX-M-15 O25b-ST131
42 Crow Chittagong Medical
College Hospital
CTX-M-15 ST2521
43 Crow Chittagong Medical
College Hospital
CTX-M-14-like O25b-ST131
44 Crow Chittagong Medical
College Hospital
CTX-M-15 ST3782a
RMCH/MDC, Rajshahi Medical College Hospital/Medical Diagnostic Centre.
aNew sequence type.
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